Trials.ai

Trials.ai focuses on the use of machine learning and AI to improve the design of clinical trial protocols. It aims to speed up the clinical trial setup and reduce the errors in protocols that may need correction over the trial’s lifespan. The solution can be deployed across all therapeutic areas, as it can cross-reference against data from medical journals, regulatory agencies, past clinical trials, and articles to assess and provide recommendations and feedback.

In terms of effectiveness, the company claimed to be able to reduce data errors for one client by 20% while saving three hours per day in administrative tasks, simply by improving the design of the trial’s protocols.

The company was acquired by ZS, a global management consulting and technology firm, in February 2023 for an undisclosed sum. The acquisition was carried out to add Trials.ai’s solution to help ZS augment how it helps its clients identify risks and reduce costs while accelerating clinical development timelines.